Published in Am J Pathol on March 05, 2009
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Extracellular matrix proteins and tumor angiogenesis. J Oncol (2010) 0.97
MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett (2012) 0.89
Hemangiogenesis and lymphangiogenesis in corneal pathology. Cornea (2012) 0.84
Emerging techniques to treat corneal neovascularisation. Eye (Lond) (2011) 0.82
Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis. Jpn J Ophthalmol (2010) 0.81
Evidence for the Involvement of MMP14 in MMP2 Processing and Recruitment in Exosomes of Corneal Fibroblasts. Invest Ophthalmol Vis Sci (2014) 0.81
VEGF Trap(R1R2) suppresses experimental corneal angiogenesis. Eur J Ophthalmol (2010) 0.81
Corneal epithelial MT1-MMP inhibits vascular endothelial cell proliferation and migration. Cornea (2010) 0.80
Nanotechnology in corneal neovascularization therapy--a review. J Ocul Pharmacol Ther (2013) 0.79
MMP regulation of corneal keratocyte motility and mechanics in 3-D collagen matrices. Exp Eye Res (2014) 0.79
TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis. PLoS One (2015) 0.78
MMP-7 knock-in corneal fibroblast cell lines secrete MMP-7 with proteolytic activity towards collagen XVIII. Curr Eye Res (2010) 0.77
Simultaneous in vivo imaging of blood and lymphatic vessel growth in Prox1-GFP/Flk1::myr-mCherry mice. FEBS J (2015) 0.77
Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and Intracellular Signaling. J Cell Physiol (2015) 0.77
Investigating the Association between Angiogenic Cytokines and Corneal Neovascularization in Sulfur Mustard Intoxicated Subjects 26 Years after Exposure. Toxicol Int (2015) 0.75
Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF-C/VEGFR-3 signaling pathway. Exp Ther Med (2016) 0.75
Molecular underpinnings of corneal angiogenesis: advances over the past decade. Int J Ophthalmol (2016) 0.75
MMP14 Cleavage of VEGFR1 in the Cornea Leads to a VEGF-Trap Antiangiogenic Effect. Invest Ophthalmol Vis Sci (2015) 0.75
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res (2005) 5.08
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A (2000) 4.22
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol (1988) 3.72
Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell (1998) 3.72
A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci (1996) 3.49
Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev (1999) 3.35
Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol (1998) 3.12
Matrix metalloproteinases: structures, evolution, and diversification. FASEB J (1998) 2.74
Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct (2001) 2.48
MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol (2004) 2.45
Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A (2000) 2.30
Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res (2006) 2.02
Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol (2003) 1.71
Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2006) 1.69
Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost (2001) 1.66
Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J Biol Chem (2001) 1.62
Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem (2000) 1.54
Corneal neovascularization. Pathogenesis and inhibition. Cornea (1987) 1.47
Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci (2001) 1.36
Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res (2004) 1.27
Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol Vis Sci (2000) 1.25
Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res (2001) 1.21
Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem (2004) 1.18
Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. Eur J Cancer (2006) 1.16
Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood (2003) 1.15
Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J Pharmacol Exp Ther (2001) 1.13
Growth factor signaling pathways in vascular development. Oncogene (1999) 1.12
Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. J Biol Chem (2002) 1.12
Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett (2001) 1.11
Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol (1997) 1.07
Immunolocalization and gene expression of matrilysin during corneal wound healing. Invest Ophthalmol Vis Sci (1999) 1.02
Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol (2006) 1.00
Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn J Cancer Res (1999) 0.97
Inhibition of corneal neovascularization by rapamycin. Exp Mol Med (2006) 0.91
Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line. Prostate (2004) 0.89
Effect of MT1-MMP deficiency and overexpression in corneal keratocytes on vascular endothelial cell migration and proliferation. Curr Eye Res (2008) 0.88
The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Exp Eye Res (1998) 0.86
Expression of type XVIII collagen during healing of corneal incisions and keratectomy wounds. Invest Ophthalmol Vis Sci (2003) 0.85
In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells. Am J Pathol (1991) 0.85
Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J Endocrinol (2003) 0.83
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea (2006) 3.18
Optimal size and location for corneal rotational autografts: a simplified mathematical model. Arch Ophthalmol (2006) 2.06
Metaanalysis of cataract development after phakic intraocular lens surgery. J Cataract Refract Surg (2008) 1.79
Infections following laser in situ keratomileusis: an integration of the published literature. Surv Ophthalmol (2004) 1.63
Ectatic disorders associated with a claw-shaped pattern on corneal topography. Am J Ophthalmol (2007) 1.61
Combined ICRS insertion and LASIK to maximize postoperative residual bed thickness in high myopia. J Cataract Refract Surg (2004) 1.39
Laser eye surgery for refractive errors. Lancet (2006) 1.37
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci (2007) 1.25
Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol (2012) 1.21
Management of traumatic cataracts. Int Ophthalmol Clin (2002) 1.18
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol (2005) 1.17
Astigmatism outcomes of horizontal temporal versus nasal clear corneal incision cataract surgery. J Cataract Refract Surg (2004) 1.16
Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett (2005) 1.10
Infectious keratitis after laser in situ keratomileusis: results of an ASCRS survey. J Cataract Refract Surg (2003) 1.07
Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature. Surv Ophthalmol (2004) 1.05
Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol (2003) 1.04
Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci (2012) 0.99
Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis. FEBS Lett (2008) 0.98
Anti-angiogenic therapy: Prospects for treatment of ocular tumors. Semin Ophthalmol (2006) 0.98
Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett (2004) 0.98
Safety, efficacy, and stability indices of LASEK correction in moderate myopia and astigmatism. J Cataract Refract Surg (2004) 0.97
Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis. Am J Pathol (2007) 0.96
A control-matched comparison of laser epithelial keratomileusis and laser in situ keratomileusis for low to moderate myopia. Am J Ophthalmol (2006) 0.95
Mitomycin-C assisted photorefractive keratectomy in the treatment of buttonholed laser in situ keratomileusis flaps associated with epithelial ingrowth. J Cataract Refract Surg (2005) 0.95
Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Invest Ophthalmol Vis Sci (2002) 0.95
Surface ablation techniques. J Cataract Refract Surg (2011) 0.95
MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. J Vasc Res (2009) 0.94
Anti-angiogenic role of angiostatin during corneal wound healing. Exp Eye Res (2004) 0.94
Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest Ophthalmol Vis Sci (2003) 0.93
Neurotrophins and nerve regeneration-associated genes are expressed in the cornea after lamellar flap surgery. Cornea (2012) 0.90
Wound healing after keratorefractive surgery: review of biological and optical considerations. Cornea (2012) 0.90
Semaphorin 7A promotes angiogenesis in an experimental corneal neovascularization model. Curr Eye Res (2011) 0.90
Confocal and electron microscopic studies of laser subepithelial keratomileusis (LASEK) in the white leghorn chick eye. Arch Ophthalmol (2002) 0.90
Semaphorin 7a links nerve regeneration and inflammation in the cornea. Invest Ophthalmol Vis Sci (2012) 0.89
Basement membrane and collagen deposition after laser subepithelial keratomileusis and photorefractive keratectomy in the leghorn chick eye. Arch Ophthalmol (2006) 0.89
In vivo serial imaging of regenerating corneal nerves after surgical transection in transgenic thy1-YFP mice. Invest Ophthalmol Vis Sci (2011) 0.89
MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett (2012) 0.89
Effect of MT1-MMP deficiency and overexpression in corneal keratocytes on vascular endothelial cell migration and proliferation. Curr Eye Res (2008) 0.88
Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves. Invest Ophthalmol Vis Sci (2012) 0.88
Analysis of customized corneal ablations: theoretical limitations of increasing negative asphericity. Invest Ophthalmol Vis Sci (2002) 0.88
Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas. Cornea (2007) 0.87
Potential complications of ocular surgery in patients with coexistent keratoconus and Fuchs' endothelial dystrophy. Ophthalmology (2006) 0.87
LASIK in the presbyopic age group: safety, efficacy, and predictability in 40- to 69-year-old patients. Ophthalmology (2007) 0.86
Corneal asphericity change after excimer laser hyperopic surgery: theoretical effects on corneal profiles and corresponding Zernike expansions. Invest Ophthalmol Vis Sci (2004) 0.86
Femtosecond-laser arcuate wedge-shaped resection to correct high residual astigmatism after penetrating keratoplasty. J Cataract Refract Surg (2006) 0.85
Corneal elevation topography: best fit sphere, elevation distance, asphericity, toricity, and clinical implications. Cornea (2011) 0.85
Expression of type XVIII collagen during healing of corneal incisions and keratectomy wounds. Invest Ophthalmol Vis Sci (2003) 0.85
Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur J Immunol (2004) 0.85
Collagen XVIII and corneal reinnervation following keratectomy. FEBS Lett (2008) 0.84
Gene therapy of the corneal epithelium. Int Ophthalmol Clin (2004) 0.84
Post-LASIK epithelial dendritic defect associated with Alternaria. Cornea (2007) 0.84
Hemangiogenesis and lymphangiogenesis in corneal pathology. Cornea (2012) 0.84
ASCRS White Paper: Management of infectious keratitis following laser in situ keratomileusis. J Cataract Refract Surg (2005) 0.84
LASEK results. Ophthalmol Clin North Am (2003) 0.84
Myopia and models and mechanisms of refractive error control. Ophthalmol Clin North Am (2002) 0.83
Restoration of electroretinogram activity in exenterated swine eyes following ophthalmic artery anastomosis. Restor Neurol Neurosci (2009) 0.83
Corneal asphericity after hyperopic laser in situ keratomileusis. J Cataract Refract Surg (2002) 0.82
Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis. Jpn J Ophthalmol (2010) 0.81
Proteomic analysis of the hyaloid vascular system regression during ocular development. J Proteome Res (2008) 0.81
Proteomic identification of activin receptor-like kinase-1 as a differentially expressed protein during hyaloid vascular system regression. FEBS Lett (2005) 0.81
VEGF Trap(R1R2) suppresses experimental corneal angiogenesis. Eur J Ophthalmol (2010) 0.81
Volume estimation of excimer laser tissue ablation for correction of spherical myopia and hyperopia. Invest Ophthalmol Vis Sci (2002) 0.80
Photochemical keratodesmos for bonding corneal incisions. Invest Ophthalmol Vis Sci (2004) 0.80
Photochemical keratodesmos as an adjunct to sutures for bonding penetrating keratoplasty corneal incisions. J Cataract Refract Surg (2004) 0.80
Corneal epithelial MT1-MMP inhibits vascular endothelial cell proliferation and migration. Cornea (2010) 0.80
Nanotechnology in corneal neovascularization therapy--a review. J Ocul Pharmacol Ther (2013) 0.79
Vector summation of anterior and posterior corneal topographical astigmatism. J Cataract Refract Surg (2002) 0.79
Femtosecond laser astigmatic keratotomy for postkeratoplasty astigmatism. Can J Ophthalmol (2008) 0.79
Characterization of the interaction between endostatin short peptide and VEGF receptor 3. Protein Pept Lett (2012) 0.79
Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer. J Refract Surg (2011) 0.78
Microkeratome-assisted posterior keratoplasty. J Cataract Refract Surg (2002) 0.78
Retracted MT1-MMP cleavage of the antiangiogenic proteoglycan decorin: role in corneal angiogenesis. Cornea (2011) 0.78